İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2009 · article

Low Density Lipoprotein Apheresis in Pediatric Patients With Homozygous Familial Hypercholesterolemia

YÖKSİS OpenAlex
Yıl2009
Atıf31OpenAlex
Atıf35Semantic Scholar · 4 etkili
Yüzdelik%83,6
FWCI1,731,00 = dünya ortalaması
Scopus (SJR)Q3
WoS (JCR)Q3

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıTherapeutic Apheresis and Dialysis
  • Katalog eşleşmesi (ISSN)Therapeutic Apheresis and Dialysis
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

The aim of the present study is to clarify the low density lipoprotein apheresis procedure for pediatric patients with homozygous familial hypercholesterolemia (FH) in terms of efficacy, adverse effects and difficulties. The follow-up was carried out using an open, prospective uncontrolled clinical design. Data were collected from 10 patients (with an average age of 8.4 +/- 4.7 years) with FH treated with double filtration plasmapheresis. The total time span of follow-up covered five years (30.2 +/- 17.8 months [range 9-60 months]) and more than 600 sessions (62.1 +/- 35.5 sessions per patient [range 18-120 sessions]) were evaluated. The mean low density lipoprotein cholesterol (LDL-C) pre-treatment value was 375.5 +/- 127.5 mg/dL, and the post-treatment value was 147.5 +/- 73.9 mg/dL. This corresponded to a 62.8 +/- 10.3% (43-73%) acute reduction of LDL-C, while the mean high density lipoprotein cholesterol losses amounted to 41%. The chronic reduction in LDL-C ranged from 18 to 52%, with a mean level of 36.4 +/- 11.7%. The most frequently occurring technical problems were related to blood lines: puncture difficulties (4.5%), insufficient blood flow (3.5%), and obturation of the blood lines (2.4%). The main clinical adverse effects were hypotension (0.2%), chills/feeling cold (0.1%), and nausea and vomiting (0.2%). We observed that the low pediatric patient tolerance is the main problem in compliance with treatment. In conclusion, LDL apheresis, started under the age of eight years, combined with lipid-lowering drugs, provides a safe and effective lowering of the mean LDL-C levels in pediatric homozygous FH; and there are more problems with compliance for pediatric LDL apheresis than in the adult population.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

31atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 21 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2018 A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)Atıf 34 · OpenAlex
  2. 2018 A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)Atıf 34 · OpenAlex
  3. 2018 A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)Atıf 34 · OpenAlex
  4. 2018 A Nation-wide Survey of Patients with Homozygous Familial Hypercholesterolemia Phenotype Undergoing LDL-apheresis in Turkey (A-HIT 1 registry)Atıf 34 · OpenAlex
  5. 2018 A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)Atıf 34 · OpenAlex
  6. 2018 A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)Atıf 34 · OpenAlex
  7. 2018 A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)Atıf 34 · OpenAlex
  8. 2024 Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolaemia: An expert consensus statement from ERKNet and ESPNAtıf 27 · OpenAlex
  9. 2019 The efficacy of double filtration plasmapheresis in the treatment of homozygous familial hypercholesterolemia: A single-center experienceAtıf 14 · OpenAlex
  10. 2016 Long term efficacy of lipoprotein apheresis in the management of familial hypercholesterolaemia Application of two different apheresis techniques in childhoodAtıf 13 · OpenAlex

Yazarlar

6
  1. MAHMUT ÇOKER 1
  2. SEMA KALKAN UÇAR 2
  3. RUHSAR DAMLA GÖKŞEN EGE ÜNİVERSİTESİ 3
  4. ŞÜKRAN DARCAN 4
  5. MUSTAFA BAK 5
  6. ŞULE CAN 6